# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-25-058337
Filing Date
2025-04-25
Accepted
2025-04-25 08:00:09
Documents
15
Period of Report
2025-06-04

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | pepg-20250424.htm iXBRL | DEF 14A | 839533
2 | GRAPHIC | img226818504_0.jpg | GRAPHIC | 22533
3 | GRAPHIC | img226818504_1.jpg | GRAPHIC | 365064
4 | GRAPHIC | img226818504_2.jpg | GRAPHIC | 207982
| Complete submission text file | 0000950170-25-058337.txt |  | 2710688

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | pepg-20250424.xsd | EX-101.SCH | 15614
17 | EXTRACTED XBRL INSTANCE DOCUMENT | pepg-20250424_htm.xml | XML | 14906

Mailing Address 1 MARINA PARK DRIVE, SUITE 900 BOSTON MA 02210
Business Address 1 MARINA PARK DRIVE, SUITE 900 BOSTON MA 02210 703-456-8000
PepGen Inc. (Filer) CIK: 0001835597 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-41374 | Film No.: 25870027
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)